BSEZENITH HEALTH CARE LTD.· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 4 Aug, 2026 · 13:27 IST

Zenith Healthcare re-appoints MD Mahendra Raycha for 3 years, AGM on Aug 28

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.6%Reaction day
₹3.17
prior close
₹3.19
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+0.2% vs market
Pharmaceuticals peers, median of 165sector-0.0%+0.7% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.6+0.4+0.2-0.0+0.7
Next day
+0.6+1.7-1.1+0.0+0.6
2d
+2.2+2.1+0.1+0.2+2.1
3d
+0.0+2.1-2.1+0.5-0.5
4d
+0.3+2.1-1.8+0.6-0.3
5d
+0.0+1.9-1.9+0.9-0.9
1w
-3.8+2.4-6.2+0.6-4.3
15d
-2.2+3.0-5.2+0.5-2.7
1m
+0.9+3.7-2.8+1.1-0.2
2m
+0.0+1.6-1.6+2.1-2.1
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zenith Healthcare board approved re-appointment of Mr. Mahendra C Raycha as Chairman and Managing Director for 3 years from July 1, 2026 to June 30, 2029 at Rs 2 lakh per month, subject to shareholder special resolution approval. AGM is scheduled for August 28, 2026 via video conferencing with record date of August 21. Mr. Raycha, age 73, is a promoter holding 12.29% stake and has served as MD for over 23 years. Annual remuneration noted as up to Rs 12 lakh per annum.

Likely market impact

Leadership continuity with promoter MD. PAT fell sharply from Rs 6.7 lakh to Rs 0.51 lakh in FY26, which may worry investors despite zero-debt status.